Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1985 1
1986 1
1989 1
1991 1
1994 1
1995 4
1996 5
1997 4
1998 1
1999 1
2005 1
2006 2
2007 4
2008 4
2009 4
2010 7
2011 4
2012 12
2013 8
2014 6
2015 8
2016 10
2017 10
2018 17
2019 16
2020 15
2021 12
2022 17
2023 13

Text availability

Article attribute

Article type

Publication date

Search Results

184 results

Results by year

Filters applied: . Clear all
Page 1
Deucravacitinib: First Approval.
Hoy SM. Hoy SM. Drugs. 2022 Nov;82(17):1671-1679. doi: 10.1007/s40265-022-01796-y. Drugs. 2022. PMID: 36401743 Free PMC article. Review.
Tezepelumab: First Approval.
Hoy SM. Hoy SM. Drugs. 2022 Mar;82(4):461-468. doi: 10.1007/s40265-022-01679-2. Drugs. 2022. PMID: 35184265 Review.
Pegcetacoplan: First Approval.
Hoy SM. Hoy SM. Drugs. 2021 Aug;81(12):1423-1430. doi: 10.1007/s40265-021-01560-8. Drugs. 2021. PMID: 34342834 Review.
Lecanemab: First Approval.
Hoy SM. Hoy SM. Drugs. 2023 Mar;83(4):359-365. doi: 10.1007/s40265-023-01851-2. Drugs. 2023. PMID: 36856953 Review.
Bexagliflozin: First Approval.
Hoy SM. Hoy SM. Drugs. 2023 Apr;83(5):447-453. doi: 10.1007/s40265-023-01848-x. Drugs. 2023. PMID: 36867399 Review.
Oteseconazole: First Approval.
Hoy SM. Hoy SM. Drugs. 2022 Jun;82(9):1017-1023. doi: 10.1007/s40265-022-01734-y. Drugs. 2022. PMID: 35713845 Review.
Patisiran: First Global Approval.
Hoy SM. Hoy SM. Drugs. 2018 Oct;78(15):1625-1631. doi: 10.1007/s40265-018-0983-6. Drugs. 2018. PMID: 30251172 Review.
Tazemetostat: First Approval.
Hoy SM. Hoy SM. Drugs. 2020 Apr;80(5):513-521. doi: 10.1007/s40265-020-01288-x. Drugs. 2020. PMID: 32166598 Review.
Pemigatinib: First Approval.
Hoy SM. Hoy SM. Drugs. 2020 Jun;80(9):923-929. doi: 10.1007/s40265-020-01330-y. Drugs. 2020. PMID: 32472305 Review.
184 results